Blocking and binding type antibodies against all major vitamin B12-binders in a pernicious anaemia serum
- PMID: 508617
- DOI: 10.1111/j.1365-2141.1979.tb03715.x
Blocking and binding type antibodies against all major vitamin B12-binders in a pernicious anaemia serum
Abstract
The simultaneous occurrence of blocking and binding antibodies to intrinsic factor (IF), transcobalamin (TC- II, TC I) and other R type vitamin B12 proteins in the serum of a patient with treated pernicious anaemia (PA) is reported here for the first time. The dialysed and purified immunoglobulin-G (IgG), but not the immunoglobulin-M (IgM), from a PA patient neutralized the total unsaturated vitamin B12 binding capacity (UB12BC) of human gastric juice, saliva and serum and also of rabbit serum, suggesting that the PA IgG contained blocking antibodies against, IF, TC II, TC I and other R-binders. In addition, the PA IgG and IgM preparations contained binding antibodies since they could form macromolecular complexes with 57Co-B12 bound to IF, TC I or TC II so that each one of the latter was totally excluded from Sephadex G-200. The presence of the binding antibodies was further confirmed by the formation of radioactive precipitation lines on agarose with each one of the vitamin B12-binders bound to 58Co-B12. The PA serum did not exhibit any measurable UB12BC after dialysis against 7.5 M guanidine-HCl followed by renaturation with phosphate buffer (pH 7.4). But it did form TC I and TC II complexes with 57Co-B12 when the latter was added during the renaturation step indicating that the serum contained circulating immunoglobulin-TC complexes. The blocking antibodies should be distinguished from the previously described binding antibodies. The blocking of the binding of vitamin B12 to TCs resulted in relatively lower serum vitamin B12 levels in the present case in contrast to the presence of binding antibodies where high serum vitamin B12 levels have been reported. In addition, the binding antibodies form immunocomplexes with TCs which can easily be detected because they can bind radioactive vitamin B12 while the corresponding immunocomplexes of blocking antibodies are hidden because they prevent the binding of the vitamin to TCs.
Similar articles
-
Inhibition of vitamin B12 binding to transcobalamin II at low pH: basis of a procedure for quantitation of circulating TC II and R binders.J Lab Clin Med. 1977 Jan;89(1):13-24. J Lab Clin Med. 1977. PMID: 12239
-
Circulating antibody to transcobalamin II causing retention of vitamin B12 in the blood.Blood. 1977 Jun;49(6):987-1000. Blood. 1977. PMID: 861380
-
The preparation of human intrinsic factor-cobalamin complex from human gastric juice by immunoadsorption.Clin Chim Acta. 1984 May 30;139(2):155-65. doi: 10.1016/0009-8981(84)90324-3. Clin Chim Acta. 1984. PMID: 6375904
-
Vitamin B12 binders (transcobalamins) in serum.Crit Rev Clin Lab Sci. 1982;18(1):1-30. doi: 10.3109/10408368209082588. Crit Rev Clin Lab Sci. 1982. PMID: 6295699 Review.
-
Autoimmune mechanisms in pernicious anaemia & thyroid disease.Autoimmun Rev. 2015 Sep;14(9):763-8. doi: 10.1016/j.autrev.2015.04.011. Epub 2015 May 1. Autoimmun Rev. 2015. PMID: 25936607 Review.
Cited by
-
Macro-B12 and Unexpectedly High Levels of Plasma B12: A Critical Review.Nutrients. 2024 Feb 26;16(5):648. doi: 10.3390/nu16050648. Nutrients. 2024. PMID: 38474776 Free PMC article. Review.
-
Diagnostic Accuracy of Holotranscobalamin, Vitamin B12, Methylmalonic Acid, and Homocysteine in Detecting B12 Deficiency in a Large, Mixed Patient Population.Dis Markers. 2020 Feb 7;2020:7468506. doi: 10.1155/2020/7468506. eCollection 2020. Dis Markers. 2020. PMID: 32089757 Free PMC article.
-
The effect of parenteral vitamin B12 treatment on its plasma metabolomic profile and on functional biomarkers of its deficiency.Sci Rep. 2025 Jul 5;15(1):24062. doi: 10.1038/s41598-025-09110-y. Sci Rep. 2025. PMID: 40617951 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous